Biology subjects

Menshikov, L.

Publications and source records attributed to Menshikov, L..

4 recordsLinked to original sources

bioRxiv2018

Identification of 12 genetic loci associated with human healthspan

The mounting challenge of preserving the quality of life in an aging population directs the focus of longevity science to the regulatory pathways controlling healthspan. To understand the nature of the relationship between the healthspan and lifespan and uncover the genetic architecture of the two phenotypes, we studied the incidence of major age-related diseases in the UK Biobank (UKB) cohort. We observed that the incidence rates of major chronic diseases increase exponentially. The risk of disease acquisition doubled approximately every eight years, i.e., at a rate compatible with the doubling time of the Gompertz mortality law. Assuming that aging is the single underlying factor behind the morbidity rates dynamics, we built a proportional hazards model to predict the risks of the diseases and therefore the age corresponding to the end of healthspan of an individual depending on their age, gender, and the genetic background. We suggested a computationally efficient procedure for the determination of the effect size and statistical significance of individual gene variants associations with healthspan in a form suitable for a Genome-Wide Association Studies (GWAS). Using the UKB sub-population of 300,447 genetically Caucasian, British individuals as a discovery cohort, we identified 12 loci associated with healthspan and reaching the whole-genome level of significance. We observed strong (|{rho}g| > 0.3) genetic correlations between healthspan and the incidence of specific age-related disease present in our healthspan definition (with the notable exception of dementia). Other examples included all-cause mortality (as derived from parental survival, with{rho} g = -0.76), life-history traits (metrics of obesity, age at first birth), levels of different metabolites (lipids, amino acids, glycemic traits), and psychological traits (smoking behaviour, cognitive performance, depressive symptoms, insomnia). We conclude by noting that the healthspan phenotype, suggested and characterized here, offers a promising new way to investigate human longevity by exploiting the data from genetic and clinical data on living individuals.

epidemiology↗

bioRxiv2017

Extracting biological age from biomedical data via deep learning: too much of a good thing?

Aging-related physiological changes are systemic and, at least in humans, are linearly associated with age. Therefore, linear combinations of physiological measures trained to estimate chronological age have recently emerged as a practical way to quantify aging in the form of biological age. Aging acceleration, defined as the difference between the predicted and chronological age was found to be elevated in patients with major diseases and is predictive of mortality. In this work, we compare three increasingly accurate biological age models: metrics derived from unsupervised Principal Components Analysis (PCA), alongside two supervised biological age models; a multivariate linear regression and a state-of-the-art deep convolution neural network (CNN). All predictions were made using one-week long locomotor activity records from a 2003-2006 National Health and Nutrition Examination Survey (NHANES) dataset. We found that application of the supervised approaches improves the accuracy of the chronological age estimation at the expense of a loss of the association between the aging acceleration predicted by the model and all-cause mortality. Instead, we turned to the NHANES death register and introduced a novel way to train parametric proportional hazards models in a form suitable for out-of-the-box implementation with any modern machine learning software. Finally, we characterized a proof-of-concept example, a separate deep CNN trained to predict mortality risks that outperformed any of the biological age or simple linear proportional hazards models. Our findings demonstrate the emerging potential of combined wearable sensors and deep learning technologies for applications involving continuous health risk monitoring and real-time feedback to patients and care providers.

bioinformatics↗

bioRxiv2017

Universal transcriptomic signature of age reveals temporal scaling of Caenorhabditis elegans aging trajectories

We collected 60 age-dependent transcriptomes for C. elegans strains including four exceptionally long-lived mutants (mean adult lifespan extended up to 9.4-fold) and three examples of RNAi treatments that increased lifespan by 19 - 35%. Principal Component Analysis (PCA) reveals aging as a transcriptomic drift along a single direction, consistent across the vastly diverse biological conditions and coinciding with the first principal component, a hallmark of the criticality of the underlying gene regulatory network. We, therefore, expected that the organisms aging state could be characterized by a single number closely related to vitality deficit or biological age. The \"aging trajectory\", i.e. the dependence of the biological age on chronological age, is then a universal stochastic function modulated by the network stiffness; a macroscopic parameter reflecting the network topology and associated with the rate of aging. To corroborate this view, we used publicly available datasets to define a transcriptomic biomarker of age and observed that the rescaling of age by lifespan simultaneously brings together aging trajectories of transcription and survival curves. In accordance with the theoretical prediction, the limiting mortality value at the plateau agrees closely with the mortality rate doubling exponent estimated at the cross-over age near the average lifespan. Finally, we used the transcriptomic signature of age to identify possible life-extending drug compounds and successfully tested a handful of the top ranking molecules in C. elegans survival assays and achieved up to a +30% extension of mean and median lifespan.

genomics↗

bioRxiv2017

Quantitative Characterization of Biological Age and Frailty Based on Locomotor Activity Records

We performed a systematic evaluation of the relationships between locomotor activity and signatures of frailty, morbidity, and mortality risks using physical activity records from the 2003 - 2006 National Health and Nutrition Examination Survey (NHANES) and UK BioBank (UKB). We proposed a statistical description of the locomotor activity tracks and transformed the provided time series into vectors representing physiological states for each participant. The Principal Components Analysis of the transformed data revealed a winding trajectory with distinct segments corresponding to subsequent human development stages. The extended linear phase starts from 35 40 years old and is associated with the exponential increase of mortality risks according to the Gompertz mortality law. We characterized the distance traveled along the aging trajectory as a natural measure of biological age and demonstrated its significant association with frailty and hazardous lifestyles, along with the remaining lifespan and healthspan of an individual. The biological age explained most of the variance of the log-hazard ratio that was obtained by fitting directly to mortality and the incidence of chronic diseases. Our findings highlight the intimate relationship between the supervised and unsupervised signatures of the biological age and frailty, a consequence of the low intrinsic dimensionality of the aging dynamics.

systems biology↗